Mass spectrometric diagnosis of septicemia
The invention mainly relates to the mass spectrometric identification of pathogens in blood cultures from blood-stream infections (septicemia). The invention provides a method with which microbial pathogens can be separated in purified form from blood after a relatively brief cultivation in a blood culture flask, without any interfering human proteins or any residual fractions of blood particles such as erythrocytes and leukocytes, and can be directly identified by mass spectrometric measurement of their protein profiles. The method is based on the use of relatively strong tensides to destroy the blood particles by dissolving the weak cell membranes and most of the internal structures of the blood particles; in spite of the fact that tensides are regarded as strong ionization inhibitors in MALDI and other ionization processes required for mass spectrometric measurements. This method allows unknown pathogens to be obtained in their pure form by centrifuging or filtration and to be identified on the taxonomic level of species or subspecies. Problems with DNA from high levels of leukocytes can be resolved by special measures. After sufficient cultivation, the identification in a mass spectrometric laboratory takes only half an hour.
1. A method for the mass spectrometric identification of microbes comprising bacteria and yeast in blood in which the microbes are deposited by centrifuging or by filtration, after which a mass spectrum is acquired from the microbes and said microbes are identified by the mass spectrum, characterized by dissolving the blood particles of a blood sample from a blood culture by adding a tenside prior to the deposition of the microbes.
2. A method for the mass spectrometric identification of microbes comprising bacteria and yeast in blood in which the microbes are deposited by sedimentation or by micro-filtration, after which a mass spectrum is acquired from the microbes and said microbes are identified by the mass spectrum, characterized by dissolving the blood particles of a blood sample from a blood culture by adding a tenside prior to deposition of the microbes.
3. A method for the mass spectrometric identification of microbes comprising bacteria and yeast in blood in which the microbes are pelleted by centrifuging or by filtration, after which a mass spectrum is acquired from the microbes and said microbes are identified by the mass spectrum, characterized by dissolving the blood particles of a blood sample from a blood culture by adding a tenside prior to pelleting of the microbes.
4. The method of claim 1 , wherein sufficient numbers of microbes in the blood are produced by cultivation.
5. The method of claim 1 , wherein the microbes deposited by centrifugation are washed and again centrifuged.
6. The method of claim 1 , wherein the tenside is added as a solution.
7. The method of claim 1 , wherein an anticoagulant is added to the blood sample.
8. The method of claim 1 , wherein one or more nucleases are added to the blood sample.
9. The method of claim 1 , wherein the blood for the blood sample is diluted with distilled water by a dilution factor between about 1:2 and 1:10.
10. The method of claim 1 , wherein the blood sample is centrifuged and the supernatant is removed before the tenside solution is added.
11. The method of claim 1 , wherein the deposited microbes are disintegrated by sonication or mechanical treatment.
12. The method of claim 1 , wherein the deposited microbes are disintegrated by solution containing formic acid or trifluoroethanoic acid and acetonitrile.
13. The method of claim 1 , wherein the preparation of measurement samples comprises transferring some of the microbes of the deposit onto a mass spectrometric sample support where a solution with a matrix substance for matrix assisted laser desorption/ionization is added.
14. The method of claim 5 , wherein sodium dodecyl sulfate (SDS) is used as the tenside.
15. The method of claim 6 , wherein the tenside solution contains a defoamer.
16. The method of claim 5 , wherein the solution is about a 5 to 20% aqueous sodium dodecyl sulfate (SDS) solution.
17. The method of claim 9 , wherein the blood for the blood sample is diluted with distilled water by a dilution factor of about 1:5.
18. The method of claim 12 , wherein the preparation of measurement samples on a mass spectrometric sample support plate is performed using a matrix substance for matrix assisted laser desorption/ionization in whose crystals the soluble proteins of the disintegrated microbes are embedded.
19. The method of claim 18 , wherein the mass spectrometric measurement is performed in a time-of-flight mass spectrometer with ionization by matrix assisted laser desorption (MALDI).